{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:05Z","timestamp":1759050605980,"version":"3.44.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jneuroim.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:32:38Z","timestamp":1535556758000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Reduced expression of the IL7Ra signaling pathway in Neuromyelitis optica"],"prefix":"10.1016","volume":"324","author":[{"given":"Livnat","family":"Brill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Lavon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.08.011_bb0005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2004.11.006","article-title":"The new paradigm of T-cell homeostatic proliferation-induced autoimmunity","volume":"26","author":"Baccala","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0020","first-page":"146","article-title":"HLA-DRB1 typing in Caucasians patients with neuromyelitis optica","volume":"53","author":"Blanco","year":"2011","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2016.02.006","article-title":"Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel","volume":"293","author":"Brill","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.smim.2012.02.006","article-title":"The influence of HIV on CD127 expression and its potential implications for IL-7 therapy","volume":"24","author":"Crawley","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0050","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.4049\/jimmunol.0903758","article-title":"Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection","volume":"184","author":"Crawley","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0055","first-page":"1581","article-title":"Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis","volume":"22","author":"De Benedetti","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.06.007","article-title":"Interleukin-7: Fuel for the autoimmune attack","volume":"45","author":"Dooms","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0070","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1007\/s00018-012-1243-7","article-title":"Review of Ets1 structure, function, and roles in immunity","volume":"70","author":"Garrett-Sinha","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","article-title":"Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis","volume":"39","author":"Gregory","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.1002099","article-title":"Ets-1 maintains IL-7 receptor expression in peripheral T cells","volume":"186","author":"Grenningloh","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/jir.2009.0060","article-title":"Interleukin 7 receptor alpha chain haplotypes vary in their influence on multiple sclerosis susceptibility and response to interferon Beta","volume":"30","author":"Hoe","year":"2010","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mcp.2010.04.006","article-title":"The genetics of multiple sclerosis: an update 2010","volume":"24","author":"Hoffjan","year":"2010","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"Icoz","year":"2010","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0100","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"International Multiple Sclerosis Genetics, C","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","article-title":"The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives","volume":"17","author":"Jasiak-Zatonska","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-015-0207-1","article-title":"Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica","volume":"3","author":"Jones","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016083","article-title":"Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica","volume":"6","author":"Kalluri","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ni.1689","article-title":"Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor","volume":"10","author":"Kerdiles","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2007.11.003","article-title":"Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis","volume":"194","author":"Kremlev","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0140","doi-asserted-by":"crossref","first-page":"93ra68","DOI":"10.1126\/scitranslmed.3002400","article-title":"IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-beta in multiple sclerosis","volume":"3","author":"Lee","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0145","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-12-800100-4.00006-4","article-title":"Immunopathogenesis of neuromyelitis optica","volume":"121","author":"Levy","year":"2014","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2007.08.015","article-title":"Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis","volume":"192","author":"Lundmark","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","article-title":"IL-7 in human health and disease","volume":"24","author":"Lundstrom","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0175","doi-asserted-by":"crossref","first-page":"E1761","DOI":"10.1073\/pnas.1222303110","article-title":"Soluble IL7Ralpha potentiates IL-7 bioactivity and promotes autoimmunity","volume":"110","author":"Lundstrom","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"Mackall","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.smim.2012.02.007","article-title":"The human IL-7 receptor gene: deletions, polymorphisms and mutations","volume":"24","author":"Mazzucchelli","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gene.6364436","article-title":"Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis","volume":"9","author":"McKay","year":"2008","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.humimm.2016.06.016","article-title":"Lymphopenia and autoimmunity: A double-edged sword","volume":"77","author":"Merayo-Chalico","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11892-014-0518-9","article-title":"Interleukin-7 and type 1 diabetes","volume":"14","author":"Monti","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015050","article-title":"Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica","volume":"5","author":"Nelson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.it.2010.10.005","article-title":"Foxo: in command of T lymphocyte homeostasis and tolerance","volume":"32","author":"Ouyang","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2009.02.003","article-title":"An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance","volume":"30","author":"Ouyang","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0230","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2015.06.034","article-title":"Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil","volume":"356","author":"Papais-Alvarenga","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","article-title":"Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival","volume":"21","author":"Park","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0245","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0255","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1073\/pnas.1617859114","article-title":"Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4","volume":"113","author":"Sagan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri2657","article-title":"Naive T cell homeostasis: from awareness of space to a sense of place","volume":"9","author":"Takada","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","article-title":"NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics","volume":"17","author":"Tsang","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0270","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0280","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1212\/WNL.0b013e318266fc2b","article-title":"T-cell reactivity against AQP4 in neuromyelitis optica","volume":"79","author":"Vaknin-Dembinsky","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.msard.2015.12.004","article-title":"T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)","volume":"6","author":"Vaknin-Dembinsky","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0295","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eji.201646855","article-title":"Deletional tolerance prevents AQP4-directed autoimmunity in mice","volume":"47","author":"Vogel","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12974-015-0403-8","article-title":"NFkappaB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG","volume":"12","author":"Walker-Caulfield","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gene.2010.49","article-title":"IL-7Ralpha confers susceptibility to experimental autoimmune encephalomyelitis","volume":"12","author":"Walline","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0310","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10067-013-2360-x","article-title":"Perspectives of the relationship between IL-7 and autoimmune diseases","volume":"32","author":"Wang","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2006.06.011","article-title":"Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis","volume":"249","author":"Warabi","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1212\/01.CON.0000389937.69413.15","article-title":"Neuromyelitis optica spectrum disorders","volume":"16","author":"Wingerchuk","year":"2010","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0325","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0330","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0335","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/labmed\/lmw053","article-title":"CD127 Expression in Naive and Memory T Cells in HIV Patients Who Have Undergone Long-Term HAART","volume":"48","author":"Xu","year":"2017","journal-title":"Lab. Med."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0345","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/infdis\/jiq101","article-title":"Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection","volume":"203","author":"Yonkers","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00401-015-1501-5","article-title":"Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS","volume":"130","author":"Zeka","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0355","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Zephir","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.08.011_bb0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.gene.6364171","article-title":"Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis","volume":"6","author":"Zhang","year":"2005","journal-title":"Genes Immun."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818302789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818302789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:26Z","timestamp":1759048406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818302789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":72,"alternative-id":["S0165572818302789"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced expression of the IL7Ra signaling pathway in Neuromyelitis optica","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}